Table 2.
First Author/year | Design | Evidence Level [16] | Duration | Dosage | Setting | Country | Sample size | Age mean | Age range | Characteristics | Gender | Sampling | Key DV | Key measure | Results | Score (max27)* [15] | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M | F | ||||||||||||||||
Spenko [28] 2006 | Pilot Intervention study | IV | § | § | Residential care | USA | “several” | § | § | § | § | § | § | Distance from wall in meters before the smart-walker changed direction | Motor performance | Good performance outcome using both PAMM technologies. Subjective measures gave less confidence in robotic-controlled walkers to manually controlled walkers. | 4 |
Saeki [32] 2008 | Case study | IV | <6 mths | 20 mins 2 d/wk for 4 mths | Home | Japan | 1 | 48 | § | Neurological | 0 | 1 | § | Oxygenated/ deoxygenated/ total haemoglobin level in motor cortex assessed by fMRI technique | Motor assessment scale (modified Ashworth Scale) | Improvement in modified Ashworth motor assessment scale (2 to 5); reduced score on modified Ashworth scale (3 to 2); no change in wrist and fine motor tasks; direct activation of motor area in affected hemisphere. | 4 |
Shimada [40] 2009 | Intervention study | III-2 | <6 mths | 2 × 90 mins/wk for 3 mths | Retirement village | Japan | 15 | 78.3 | 72–85 | Healthy | 0 | 15 | Conven-ience | Walking speed | 5 m walk test | Increase in walking speed; reduction in energy consumption (lower glucose metabolism) | 12 |
Carlson and Demiris [51] 2012 | Intervention study | III-2 | <1 d | 2 × 40 mins | Simulated “home” environment | England | 21 | § | 17–47 | Healthy | § | § | Conven-ience | Wheel-chair control around a simulated home environment | Collision and cognitive perception | Less collisions with robotic assistance and lower scores on perceptions of concentration | 13 |
§Not given.
*The last question of the Downs and Black assessment tool was excluded due to ambiguity of the question. This meant that the maximum score possible was 27.